NOI to sole source under SAT.docx
DOCX document 22 KB Posted
- Attached to
- Notice of Intent to Sole Source – Roche Diagnostics BenchMark ULTRA Reagents & Consumables
- Solicitation number
- NOI-OD-26-006334
About this file
This is a Notice of Intent to Sole Source a one-year contract for Roche Ventana BenchMark ULTRA reagents, consumables, and services for immunohistochemistry (IHC) and in-situ hybridization (ISH) testing. The contract period runs from September 1, 2026 through August 31, 2027 and is being procured by the National Institutes of Health Clinical Center to support the Division of Laboratory Medicine's Hematology Bone Marrow Pathology and Consultation Service. The procurement is conducted under FAR Part 13 Simplified Acquisition Procedures, specifically Subpart 13.106-1(b)(1), which allows single-source solicitation for purchases not exceeding the simplified acquisition threshold when the contracting officer determines only one source is reasonably available. As a Part 13 procurement, the contract is exempt from FAR Part 6 competition requirements.
The Notice of Intent was posted on August 11, 2026 with a close date of August 23, 2026 at 12:00 PM EST. The end user is the NIH Clinical Center. Interested parties may submit comments regarding this sole-source determination to Ryssa Nix, Contract Specialist, at the NIH Clinical Center Office of Purchasing and Contracts via email to Ryssa.nix@nih.gov prior to the close date. The procurement is classified under NAICS Code 541690 and PSC Code 6550.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Notice Number: NOI-OD-26-006334 Title: Notice of Intent to Sole Source – Roche Diagnostics BenchMark ULTRA Reagents & Consumables Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
This procurement is for a one-year (09/01/2026 – 08/31/2027) contract for Roche Ventana BenchMark ULTRA reagents, consumables, service for immunohistochemistry (IHC) and in-situ hybridization (ISH) testing. This purchasing agreement is needed to maintain clinically relevant patient testing with Roche branded IHC and ISH materials to meet the need of the DLM’s Hematology Bone Marrow Pathology and Consultation Service.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.
Notice Type: Notice of Intent NAICS Code: 541690 PSC Code: 6550 Posted Date: 08/11/2026 Close Date: 08/23/2026 12pm EST End User IC: Clinical Center POC Name: Ryssa Nix Email Address: Ryssa.nix@nih.gov
File details come from the government source that posted it. Updated .